Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Intern Emerg Med. 2016 Dec 2;12(1):103–111. doi: 10.1007/s11739-016-1583-7

Fig. 4.

Fig. 4

Cumulative ranking probabilities for each treatment in the network. The surface under the cumulative ranking curve (SUCRA) value is the probability each treatment has of being among the best of those in the network, with larger values representing higher ranking probabilities. In this figure, the top three treatments are bimatoprost, latanoprost, and travoprost, with SUCRA values of 99.6%, 86.56%, and 85.76%, respectively [8]